Coral Medical Care is one of the most widely used cancer care providers in the world.
But the Coral team recently revealed a troubling statistic.
The Coral team has received $8.3 million in taxpayer dollars over the last four years, and nearly half of that went to pay for a single patient who was diagnosed with stage IV cancer.
But Coral paid that patient more than $7,500 in costs related to his treatment, including $1,000 to cover his medical bills.
The average cost of treatment at Coral for a patient with cancer was $764.
The average cost for a typical treatment for a similar person with stage III cancer was about $2,500.
The Coral team said it has spent the money to pay its patients’ medical bills, and is continuing to make improvements to its treatment programs.
But some patients who would have benefited from a lower-cost approach to cancer care have had their health care bills spiked.
The Miami Herald reported that in 2017, Coral spent $2.5 million for cancer care for a cancer patient who did not need treatment at all.
The cost of that treatment was more than double what it was for the same person without cancer.
The Herald found that, in total, Coral has paid $7.3 billion in taxpayer-funded cancer care.
That’s a lot of money.
But the Coral Care team argues that it is paying its patients the best it can for the best outcomes.
“We pay our patients what we can because we understand the value of the patient and how we can improve the patient’s care,” Coral Health Director of Health Services Chris Schaffer said in a statement.
“The most important thing for our patients is to get better care.
We strive to provide the best care we can for our most vulnerable patients, and we do not expect to make any profit from our cancer care.”
Coral has not responded to multiple requests for comment.
Coral says it pays its doctors the same rates as other doctors and is transparent about the cost of care.
But there is a problem with this claim.
The truth is that the average cost to a doctor of $765 for a routine consultation is far higher than the cost to patients for treatment.
The cost to treatment for patients with cancer is based on the median cost of treating a patient at a hospital or clinic, not the cost for the actual treatment.
Cancer Care, the Coral company, says its cost of health care includes the following:The average patient with stage II cancer, $1.7 million in 2017Cost of treatment for stage III or IV cancer patients, $5.6 million in 2016The cost of cancer care to the average American, $2 million in 2020The cost for treatment of a person with advanced stage III, or advanced stage IV, cancer, at a facility such as a hospital, clinic, or other medical facilityThe cost per patient, $766In the past, the average person had to pay more than two-thirds of their healthcare bills.
But that has not always been the case.
For example, a study in The Journal of the American Medical Association showed that the majority of Medicare beneficiaries in the 1960s and 1970s had to shell out over a third of their premiums for health care.
In a 2013 paper, Harvard Medical School professor David Cutler found that people with cancer pay roughly 30 percent more for their health insurance than people without cancer, and that people who have cancer also pay more for health insurance.
Cheryl M. Hiltzik, a spokeswoman for the U.S. Department of Health and Human Services, said that Coral paid the people who needed its services the lowest possible rate because they were receiving care from an expert and had no insurance problems.
“This practice is very common in Medicare.
It is one example of how the Medicare system operates to reduce cost and to reduce the number of people in need of care,” Hiltik said.
“It is a good practice and we are committed to keeping this practice in place.”
In the meantime, the cost at Coral is out of control.
The Herald reported on Monday that the cost per treatment at the Coral facility in Miami was more expensive than at other medical centers in the United States.
Hiltzik said the company is working to make its care even more affordable for its patients.
But she said it would not make a profit from its cancer care programs.
“Coral is focused on continuing to improve care and patient outcomes,” she said.
The company said it will spend more than any other company on care for its uninsured patients.
Coron, the largest cancer treatment company in the country, is now paying out more than half of its costs to uninsured patients, according to a report from the Kaiser Family Foundation.
The other half is going to Medicare, which pays 80 percent of the cost.
Cochran Health Solutions, the company that operates Coral’s hospitals and clinics, said